T cell receptor engineering and analysis using the yeast display platform

Methods in Molecular Biology

Volumn 1319, Issue , 2015, Pages 95-141

  Smith, Sheena N ^a   Harris, Daniel T ^a   Kranz, David M ^a  

^a NONE

Author keywords

Affinity maturation; Intracellular antigens; Major histocompatibility complex; Peptide antigens; Singlechain T cell receptors; T cell receptors; Yeast display

Indexed keywords

ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR; ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE LIBRARY; PROTEIN BINDING;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISPLAY SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SACCHAROMYCES CEREVISIAE; T LYMPHOCYTE ACTIVATION; BINDING SITE; BIOSYNTHESIS; CHEMISTRY; GENETICS; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLISM; PEPTIDE LIBRARY; PROCEDURES; PROTEIN ENGINEERING;

ANTIGENS; BINDING SITES; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE LIBRARY; PROTEIN BINDING; PROTEIN ENGINEERING; RECEPTORS, ANTIGEN, T-CELL; SACCHAROMYCES CEREVISIAE;

EID: 84931265899     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2748-7_6     Document Type: Article

References (57)

1. Davis MM, Boniface JJ, Reich Z et al (1998) Ligand recognition by alpha beta T cell receptors. Annu Rev Immunol 16:523–544
2. Davis MM, Krogsgaard M, Huppa JB et al (2003) Dynamics of cell surface molecules during T cell recognition. Annu Rev Biochem 72:717–742
3. van der Merwe PA, Davis SJ (2003) Molecular interactions mediating T cell antigen recognition. Annu Rev Immunol 21:659–684
4. Davis MM, Krogsgaard M, Huse M et al (2007) T cells as a self-referential, sensory organ. Annu Rev Immunol 25:681–695. doi: 10.1146/annurev.immunol.24.021605.090600
5. Garcia KC, Teyton L, Wilson IA (1999) Structural basis of T cell recognition. Annu Rev Immunol 17:369–397
6. Marrack P, Scott-Browne JP, Dai S et al (2008) Evolutionarily conserved amino acids that control TCR-MHC interaction. Annu Rev Immunol 26:171–203
7. Van Laethem F, Tikhonova AN, Pobezinsky LA et al (2013) Lck availability during thymic selection determines the recognition specificity of the T cell repertoire. Cell 154:1326–1341. doi: 10.1016/j.cell.2013.08.009,S0092-8674(13)01003-9 [pii]
8. Li Y, Yin Y, Mariuzza RA (2013) Structural and biophysical insights into the role of CD4 and CD8 in T cell activation. Front Immunol 4:206. doi: 10.3389/fimmu.2013.00206
9. Garcia KC, Adams JJ, Feng D et al (2009) The molecular basis of TCR germline bias for MHC is surprisingly simple. Nat Immunol 10:143–147. doi:10.1038/ni.f.219,ni.f.219 [pii]
10. Kranz DM (2009) Two mechanisms that account for major histocompatibility complex restriction of T cells. F1000 Biol Rep 1:55–58
11. Holler PD, Holman PO, Shusta EV et al (2000) In vitro evolution of a T cell receptor with high affinity for peptide/MHC. Proc Natl Acad Sci U S A 97:5387–5392
12. Holler PD, Chlewicki LK, Kranz DM (2003) TCRs with high affinity for foreign pMHC show self-reactivity. Nat Immunol 4:55–62
13. Weber KS, Donermeyer DL, Allen PM et al (2005) Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function. Proc Natl Acad Sci U S A 102:19033–19038
14. Li Y, Moysey R, Molloy PE et al (2005) Directed evolution of human T-cell receptors with picomolar affi nities by phage display. Nat Biotechnol 23:349–354
15. Liddy N, Bossi G, Adams KJ et al (2012) Monoclonal TCR-redirected tumor cell killing. Nat Med 18:980–987. doi: 10.1038/nm.2764,nm.2764 [pii]
16. Chames P, Willemsen RA, Rojas G et al (2002) TCR-like human antibodies expressed on human CTLs mediate antibody affinitydependent cytolytic activity. J Immunol 169:1110–1118
17. Cohen CJ, Sarig O, Yamano Y et al (2003) Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHCrestricted human recombinant antibodies. J Immunol 170:4349–4361
18. Denkberg G, Stronge VS, Zahavi E et al (2008) Phage display-derived recombinant antibodies with TCR-like specificity against alpha- galactosylceramide and its analogues in complex with human CD1d molecules. Eur J Immunol 38:829–840. doi: 10.1002/eji.200737518
19. Verma B, Neethling FA, Caseltine S et al (2010) TCR mimic monoclonal antibody targets a specific peptide/HLA class I complex and significantly impedes tumor growth in vivo using breast cancer models. J Immunol 184:2156–2165. doi: 10.4049/jimmunol.0902414,jimmunol.0902414 [pii]
20. Mareeva T, Martinez-Hackert E, Sykulev Y (2008) How a T cell receptor-like antibody recognizes major histocompatibility complexbound peptide. J Biol Chem 283:29053–29059. doi: 10.1074/jbc.M804996200,M804996200 [pii]
21. Richman SA, Kranz DM (2007) Display, engineering, and applications of antigen-specific T cell receptors. Biomol Eng 24:361–373
22. Stone JD, Chervin AS, Aggen DH et al (2012) T cell receptor engineering. Methods Enzymol 503:189–222. doi: 10.1016/B978-0-12-396962-0.00008-2,B978-0-12-396962-0.00008-2 [pii]
23. Oates J, Jakobsen BK (2013) ImmTACs: novel bi-specific agents for targeted cancer therapy. Oncoimmunology 2:e22891. doi: 10.4161/onci.22891,2012ONCOIMM0357 [pii]
24. Stone JD, Yin Y, Mo M et al (2012) Engineering high-affinity T cell receptor/ cytokine fusions for therapeutic targeting. In Kaumaya P (ed) Protein engineering, ISBN: 978-953-51-0037-9, InTech
25. Stone JD, Chervin AS, Schreiber H et al (2012) Design and characterization of a protein superagonist of IL-15 fused with IL-15Ralpha and a high-affinity T cell receptor. Biotechnol Prog 28:1588–1597. doi: 10.1002/btpr.1631
26. Soto CM, Stone JD, Chervin AS et al (2013) MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCR. Cancer Immunol Immunother 62:359–369. doi: 10.1007/s00262-012-1336-z
27. Stone JD, Kranz DM (2013) Role of T cell receptor affinity in the efficacy and specifi city of adoptive T cell therapies. Front Immunol 2444:. doi: 10.3389/fimmu.2013.00244
28. Zhao Y, Bennett AD, Zheng Z et al (2007) High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines. J Immunol 179:5845–5854
29. Chervin AS, Stone JD, Holler PD et al (2009) The impact of TCR-binding properties and antigen presentation format on T cell responsiveness. J Immunol 183:1166–1178. doi: 10.4049/jimmunol.0900054,jimmunol.0900054 [pii]
30. Kieke MC, Shusta EV, Boder ET et al (1999) Selection of functional T cell receptor mutants from a yeast surface- display library. Proc Natl Acad Sci U S A 96:5651–5656
31. Richman SA, Aggen DH, Dossett ML et al (2009) Structural features of T cell receptor variable regions that enhance domain stability and enable expression as single-chain ValphaVbeta fragments. Mol Immunol 46:902–916. doi: 10.1016/j.molimm.2008.09.021,S0161-5890(08)00665-2 [pii]
32. Aggen DH, Chervin AS, Insaidoo FK et al (2011) Identification and engineering of human variable regions that allow expression of stable single-chain T cell receptors. Protein Eng Des Sel 24:361–372
33. Smith SN, Sommermeyer D, Piepenbrink KH et al (2013) Plasticity in the contribution of T cell receptor variable region residues to binding of peptide-HLA-A2 complexes. J Mol Biol. doi: 10.1016/j.jmb.2013.08.007,S0022-2836(13)00510-X [pii]
34. Boder ET, Wittrup KD (1997) Yeast surface display for screening combinatorial polypeptide libraries. Nat Biotechnol 15:553–557
35. Shusta EV, Kieke MC, Parke E et al (1999) Yeast polypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency. J Mol Biol 292:949–956
36. Shusta EV, Holler PD, Kieke MC et al (2000) Directed evolution of a stable scaffold for T-cell receptor engineering. Nat Biotechnol 18:754–759
37. Boder ET, Wittrup KD (2000) Yeast surface display for directed evolution of protein expression, affi nity, and stability. Methods Enzymol 328:430–444
38. Feldhaus M, Siegel R, Opresko L et al (2003) Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library. Nat Biotechnol 21: 163–170
39. Gai SA, Wittrup KD (2007) Yeast surface display for protein engineering and characterization. Curr Opin Struct Biol 17:467–473. doi: 10.1016/j.sbi.2007.08.012,S0959-440X(07)00119-4 [pii]
40. Chao G, Lau WL, Hackel BJ et al (2006) Isolating and engineering human antibodies using yeast surface display. Nat Protoc 1: 755–768. doi: 10.1038/nprot.2006.94,nprot.2006.94 [pii]
41. Benatuil L, Perez JM, Belk J et al (2010) An improved yeast transformation method for the generation of very large human antibody libraries. Protein Eng Des Sel 23:155–159. doi: 10.1093/protein/gzq002,gzq002 [pii]
42. Soo Hoo WF, Lacy MJ, Denzin LK et al (1992) Characterization of a single-chain T cell receptor expressed in E. Coli.Proc Natl Acad Sci 89:4759–4763
43. Gietz RD, Schiestl RH, Willems A et al (1995) Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast 11:355–360
44. Richman SA, Kranz DM, Stone JD (2009) Biosensor detection systems: engineering stable, high-affinity bioreceptors by yeast surface display. Methods Mol Biol 504:323–350. doi: 10.1007/978-1-60327-569-9_19
45. Dal Porto J, Johansen TE, Catipovic B et al (1993) A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations. Proc Natl Acad Sci U S A 90:6671–6675
46. Altman JD, Moss PAH, Goulder PJR et al (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94–96
47. Stone JD, Artyomov MN, Chervin AS et al (2011) Interaction of streptavidin-based peptide- MHC oligomers (tetramers) with cellsurface TCRs. J Immunol 187:6281–6290. doi: 10.4049/jimmunol.1101734,jimmunol.1101734 [pii]
48. Garboczi DN, Ghosh P, Utz U et al (1996) Structure of the complex between human T-cell receptor, viral peptide and HLA-A 2. Nature 384:134–141
49. Garboczi DN, Utz U, Ghosh P et al (1996) Assembly, specific binding, and crystallization of a human TCR-alphabeta with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLAA 2. J Immunol 157:5403–5410
50. Toebes M, Coccoris M, Bins A et al (2006) Design and use of conditional MHC class I ligands. Nat Med 12:246–251. doi: 10.1038/nm1360,nm1360 [pii]
51. Stone JD, Chervin AS, Kranz DM (2009) T-cell receptor binding affi nities and kinetics: impact on T-cell activity and specificity. Immunology 126:165–176. doi: 10.1111/j.1365-2567.2008.03015.x,IMM3015 [pii]
52. Rudolph MG, Stanfi eld RL, Wilson IA (2006) How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 24: 419–466
53. Chlewicki LK, Holler PD, Monti BC et al (2005) High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR 3. J Mol Biol 346:223–239
54. Dunn SM, Rizkallah PJ, Baston E et al (2006) Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity. Protein Sci 15:710–721
55. Horton RM, Cai ZL, Ho SN et al (1990) Gene splicing by overlap extension: tailormade genes using the polymerase chain reaction. Biotechniques 8:528–535
56. Chervin AS, Stone JD, Soto CM et al (2013) Design of T-cell receptor libraries with diverse binding properties to examine adoptive T-cell responses. Gene Ther 20(6):634–644. doi: 10.1038/gt.2012.80
57. Orr BA, Carr LM, Wittrup KD et al (2003) Rapid method for measuring ScFv thermal stability by yeast surface display. Biotechnol Prog 19:631–638